ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    AZD3759
Previous Study | Return to List | Next Study

Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer (BLOOM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02228369
Recruitment Status : Active, not recruiting
First Posted : August 29, 2014
Last Update Posted : June 8, 2018
Sponsor:
Information provided by (Responsible Party):
AstraZeneca